| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kennedy Lewis GP III LLC | Director | 225 LIBERTY STREET, SUITE 4210, NEW YORK | KENNEDY LEWIS GP III LLC, By: Kennedy Lewis Investment Holdings II LLC, its managing member, /s/ Anthony Pasqua, Title: Authorized Person | 30 Jun 2025 | 0001897209 |
| Kennedy Lewis Investment Holdings II LLC | Director | 225 LIBERTY STREET, SUITE 4210, NEW YORK | KENNEDY LEWIS INVESTMENT HOLDINGS II LLC, Name: /s/ Anthony Pasqua, Title: Authorized Person | 30 Jun 2025 | 0001854977 |
| KLIM Delta HQC3 LP | Director | 225 LIBERTY STREET, SUITE 4210, NEW YORK | KLIM DELTA HQC3 LP, By: Kennedy Lewis GP III LLC, its general partner, By: Kennedy Lewis Investment Holdings II LLC, its managing member, Name: /s/ Anthony Pasqua, Title: Authorized Person | 30 Jun 2025 | 0001994226 |
| KLCP Fund III (EU) Master AIV LP | Director | 225 LIBERTY STREET, SUITE 4210, NEW YORK | KLCP FUND III (EU) MASTER AIV LP, By: Kennedy Lewis GP III LLC, its general partner, By: Kennedy Lewis Investment Holdings II LLC, its managing member, Name: /s/ Anthony Pasqua, Title: Authorized Person | 30 Jun 2025 | 0002029655 |
| CHENE DAVID | Director | 225 LIBERTY STREET, SUITE 4210, NEW YORK | DAVID CHENE, Name: /s/ David Chene | 30 Jun 2025 | 0001797237 |
| Richman Darren | Director | 225 LIBERTY STREET, SUITE 4210, NEW YORK | DARREN RICHMAN, Name: /s/ Darren Richman | 30 Jun 2025 | 0001594474 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DOUG | Common Stock | Award | $0 | +61,983 | +105% | $0.000000 | 120,958 | 28 Jun 2025 | See Footnotes | F1, F2, F3, F4, F6, F7 |
| transaction | DOUG | Common Stock | Award | $0 | +61,983 | +105% | $0.000000 | 120,958 | 28 Jun 2025 | See Footnotes | F1, F2, F3, F5, F6, F7 |
| Id | Content |
|---|---|
| F1 | On June 28, 2025, Douglas Elliman Inc. (the "Issuer") granted 61,983 shares of restricted Common Stock to David Chene, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Chene holds the shares of restricted Common Stock for the benefit of KLIM Delta HQC3 LP ("KLIM Delta") and KLCP Fund III (EU) Master AIV LP ("KLCP Fund III", and together with KLIM Delta, the "Funds"). Because Mr. Chene serves on the Board as a representative of the Funds and their affiliates, Mr. Chene does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position and the Funds are entitled to an indirect proportionate pecuniary interest in any securities granted to Mr. Chene by the Issuer in respect of Mr. Chene's Board position. |
| F2 | (Continued from footnote 1) Mr. Chene disclaims any direct beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Chene had any economic interest in such securities except any indirect economic interest through interests in the Funds and their affiliates. The restricted stock award was granted under the Issuer's 2021 Management Incentive Plan, and vests in two equal annual installments on each of June 28, 2026 and June 28, 2027, subject to Mr. Chene's continued service through each such vesting date or earlier vesting upon Mr. Chene's death or disability or a change-of-control. |
| F3 | The 61,983 shares of restricted Common Stock are reported for each of the Funds as each has an indirect pecuniary interest. |
| F4 | As described in footnotes (1) and (2), the reported securities represent shares of restricted Common Stock in which KLIM Delta may be deemed to have an indirect proportionate pecuniary interest. |
| F5 | As described in footnotes (1) and (2), the reported securities represent shares of restricted Common Stock in which KLCP Fund III may be deemed to have an indirect proportionate pecuniary interest. |
| F6 | Kennedy Lewis GP III LLC ("Kennedy Lewis GP III") is the general partner of each of the Funds. Kennedy Lewis Investment Holdings II LLC ("Holdings II") is the managing member of Kennedy Lewis GP III. Holdings II is controlled by its board of managers. David Chene and Darren Richman, each a Manager of Holdings II, are the effective control persons of Holdings II. Each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman may be deemed to exercise voting and investment power over and thus may be deemed to beneficially own the securities held by the Funds due to their relationship with the Funds. |
| F7 | For purposes of Section 16 of the Securities Exchange Act of 1934, each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman disclaims beneficial ownership of the securities of the Issuer held directly by the Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of Kennedy Lewis GP III, Holdings II, David Chene or Darren Richman is the beneficial owner of such securities for purposes of Section 16 or any other purpose. |
David Chene, a Manager of Kennedy Lewis Investment Holdings II LLC, serves on the Board of Directors of Douglas Elliman Inc. (the "Issuer"). By virtue of their representation on the Board of Directors of the Issuer, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each of the reporting persons other than Mr. Chene are deemed directors by deputization of the Issuer.